PRECIGEN pipeline

Discovery
by Design

Our growing pipeline of multifunctional gene and cell therapy candidates gives us distinct advantages for combination strategies. Our preclinical and clinical pipeline includes several programs leveraging our technologies in core therapeutic areas of immuno-oncology, autoimmune disorders, and infectious diseases.

Clinical Pipeline

As of May 10, 2021

Preclinical Pipeline

As of May 10, 2021
Therapeutic AreaProductPlatformIndicationDiscoveryPreclinicalPhase 1Phase 2Phase 3
Immuno-OncologyPRGN-3007UltraCAR-TUndisclosed
Immuno-OncologyPRGN-3008UltraCAR-TUndisclosed
Immuno-OncologyPRGN-5001Multifunctional TherapeuticSolid Tumors
Immuno-OncologyPRGN-2010OTS AdenoVerse ImmunotherapySolid Tumors
Immuno-OncologyPRGN-2011AdenoVerse Cytokine TherapySolid Tumors
Immuno-OncologyPRGN-5002Multifunctional TherapeuticSolid Tumors
Infectious DiseasePRGN-2013OTS AdenoVerse ImmunotherapyChronic Hepatitis B
Autoimmune DisordersAG017ActoBioticsCeliac Disease
Autoimmune DisordersPRGN-3009UndisclosedUndisclosed
Autoimmune DisordersPRGN-3010UndisclosedUndisclosed